Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates
- Citation:
- Ann Surg vol 262 (3) 434-439
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Presented as an Oral Presentation at the 135th Annual meeting of the American Surgical Association, April 2015
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 5
- Parents:
- 2296
- Children:
- None
- Pharmas:
- Grants:
- U10 CA180821, U10CA180882, P30 CA008748, U10 CA180791, U10CA180791, U10CA180867, U10 CA180882, CA180888, U10CA180821, U10 CA180867, U10 CA180888
- Corr. Author:
- Mehra Golshan
- Authors:
- Mehra Golshan Constance T. Cirrincione William M. Sikov Donald A. Berry Sara Jasinski Tracey F. Weisberg George Somlo Clifford Hudis Eric Winer David W. Ollila
- Networks:
- CA043, LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016, RI005
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- breast-conserving therapy, mastectomy, neoadjuvant therapy, surgery, triple negative breast cancer